Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mise

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Archives of Virology|September 1, 2005
Comparison of NSP4 protein between group A and B human rotaviruses: detection of novel diarrhea-causing sequences in group B NSP4M Ishino, K Mise, H Takemura, et al.
Human Cell|September 1, 1988
[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes]N Kan, T Okino, M Nakanishi, et al.
Epidemiology and Infection|December 17, 2013
Seasonality of reported tuberculosis cases from 2006 to 2010 in Wuhan, ChinaT Luo, A Sumi, D Zhou, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytesM Nakanishi, N Kan, T Okino, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancersK Satoh, N Kan, T Okino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]N Kan, T Okino, K Satoh, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapyK Satoh, N Kan, T Okino, et al.
Cancer Research|October 1, 1990
Effect of heat treatment on tumor cells and antitumor effector cellsK Mise, N Kan, T Okino, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytomaN Kan, T Okino, M Nakanishi, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusionT Hori, K Mise, N Kan, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Archives of Virology|September 1, 2005
Comparison of NSP4 protein between group A and B human rotaviruses: detection of novel diarrhea-causing sequences in group B NSP4M Ishino, K Mise, H Takemura, et al.
Human Cell|September 1, 1988
[Clinical therapeutic effect of adoptive immunotherapy using IL-2-cultured autologous lymphocytes]N Kan, T Okino, M Nakanishi, et al.
Epidemiology and Infection|December 17, 2013
Seasonality of reported tuberculosis cases from 2006 to 2010 in Wuhan, ChinaT Luo, A Sumi, D Zhou, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytesM Nakanishi, N Kan, T Okino, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancersK Satoh, N Kan, T Okino, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1990
[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy]N Kan, T Okino, K Satoh, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
A murine plasmacytoma MOPC 104E resistant to cyclophosphamide is resistant to immunotherapyK Satoh, N Kan, T Okino, et al.
Cancer Research|October 1, 1990
Effect of heat treatment on tumor cells and antitumor effector cellsK Mise, N Kan, T Okino, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytomaN Kan, T Okino, M Nakanishi, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Therapeutic and life-prolonging effect of intrapleural injection with a streptococcal preparation, OK-432, and IL2-cultured effusion lymphocytes to breast cancer patients with malignant pleural effusionT Hori, K Mise, N Kan, et al.
Pageof 12